TY - JOUR
T1 - Immunotherapy for advanced and recurrent malignant pleural mesothelioma
AU - Haugaard, Anna Karen
AU - Saude Conde, Rita
AU - J Maria, Ana Rita
AU - Vithal Yergolkar, Abhijna
AU - Jørgensen, Karsten Juhl
AU - Heleno, Bruno
N1 - Publisher Copyright:
Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2024/9/18
Y1 - 2024/9/18
N2 - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.
AB - This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.
KW - Humans
KW - Immune Checkpoint Inhibitors/therapeutic use
KW - Immunotherapy/methods
KW - Lung Neoplasms/therapy
KW - Mesothelioma, Malignant/therapy
KW - Mesothelioma/therapy
KW - Neoplasm Recurrence, Local
KW - Pleural Neoplasms/therapy
KW - Randomized Controlled Trials as Topic
KW - Salvage Therapy/methods
UR - http://www.scopus.com/inward/record.url?scp=85204475296&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD014720
DO - 10.1002/14651858.CD014720
M3 - Journal article
C2 - 39291744
AN - SCOPUS:85204475296
SN - 1465-1858
VL - 2024
SP - CD014720
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 9
M1 - CD014720
ER -